ArticleClinical and translational science2026

Efavirenz and CYP2C9 Genetic Polymorphisms Reduce CYP2C9 Activity in Healthy Participants.

Jason D Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.